BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Waldum HL, Kleveland PM, Sandvik AK, Brenna E, Syversen U, Bakke I, Tømmerås K. The cellular localization of the cholecystokinin 2 (gastrin) receptor in the stomach. Pharmacol Toxicol 2002;91:359-62. [PMID: 12688379 DOI: 10.1034/j.1600-0773.2002.910613.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 0.7] [Reference Citation Analysis]
Number Citing Articles
1 Fornai M, Colucci R, Antonioli L, Crema F, Buccianti P, Chiarugi M, Baschiera F, Ghisu N, Tuccori M, Blandizzi C. Cholecystokinin CCK2 receptors mediate the peptide's inhibitory actions on the contractile activity of human distal colon via the nitric oxide pathway. Br J Pharmacol. 2007;151:1246-1253. [PMID: 17572695 DOI: 10.1038/sj.bjp.0707339] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
2 Watson SA, Grabowska AM, El-Zaatari M, Takhar A. Gastrin - active participant or bystander in gastric carcinogenesis? Nat Rev Cancer. 2006;6:936-946. [PMID: 17128210 DOI: 10.1038/nrc2014] [Cited by in Crossref: 92] [Cited by in F6Publishing: 79] [Article Influence: 6.6] [Reference Citation Analysis]
3 Faridi MS, Jaiswal MS, Goel SK. Expression of CCK Receptors in Carcinoma Gallbladder and Cholelithiasis: A Pilot Study. J Clin Diagn Res. 2015;9:PC04-PC07. [PMID: 26393162 DOI: 10.7860/jcdr/2015/12697.6152] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
4 Zhu J, Chen L, Xia H, Luo HS. Mechanisms mediating CCK-8S-induced contraction of proximal colon in guinea pigs. World J Gastroenterol 2010; 16(9): 1076-1085 [PMID: 20205277 DOI: 10.3748/wjg.v16.i9.1076] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
5 Waldum HL, Fossmark R, Bakke I, Martinsen TC, Qvigstad G. Hypergastrinemia in animals and man: causes and consequences. Scand J Gastroenterol 2004;39:505-9. [PMID: 15223671 DOI: 10.1080/00365520410005072] [Cited by in Crossref: 26] [Cited by in F6Publishing: 19] [Article Influence: 1.5] [Reference Citation Analysis]
6 Chen D, Friis-hansen L, Håkanson R, Zhao C. Genetic dissection of the signaling pathways that control gastric acid secretion. Inflammopharmacol 2005;13:201-7. [DOI: 10.1163/156856005774423872] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
7 Kim HJ, Kang TW, Haam K, Kim M, Kim SK, Kim SY, Lee SI, Song KS, Jeong HY, Kim YS. Whole genome MBD-seq and RRBS analyses reveal that hypermethylation of gastrointestinal hormone receptors is associated with gastric carcinogenesis. Exp Mol Med. 2018;50:156. [PMID: 30510283 DOI: 10.1038/s12276-018-0179-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
8 Shulkes A, Baldwin GS, Giraud AS. Regulation of Gastric Acid Secretion. Physiology of the Gastrointestinal Tract. Elsevier; 2006. pp. 1223-58. [DOI: 10.1016/b978-012088394-3/50052-0] [Cited by in Crossref: 11] [Article Influence: 0.7] [Reference Citation Analysis]
9 Kaur K, Talele TT. 3D QSAR studies of 1,3,4-benzotriazepine derivatives as CCK2 receptor antagonists. Journal of Molecular Graphics and Modelling 2008;27:409-20. [DOI: 10.1016/j.jmgm.2008.07.003] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
10 Friis-hansen L, Schjerling CK, de la Cour CD, Håkanson R, Rehfeld JF. Characteristics of gastrin controlled ECL cell specific gene expression. Regulatory Peptides 2007;140:153-61. [DOI: 10.1016/j.regpep.2006.12.006] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
11 Fornai M, Colucci R, Antonioli L, Baschiera F, Ghisu N, Tuccori M, Gori G, Blandizzi C, Del Tacca M. CCK2 receptors mediate inhibitory effects of cholecystokinin on the motor activity of guinea-pig distal colon. Eur J Pharmacol 2007;557:212-20. [PMID: 17208221 DOI: 10.1016/j.ejphar.2006.11.039] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
12 Scarpignato C, Pelosini I, Di Mario F. Acid suppression therapy: Where do we go from here? Dig Dis. 2006;24:11-46. [PMID: 16699262 DOI: 10.1159/000091298] [Cited by in Crossref: 61] [Cited by in F6Publishing: 54] [Article Influence: 4.1] [Reference Citation Analysis]
13 Dufresne M, Seva C, Fourmy D. Cholecystokinin and gastrin receptors. Physiol Rev 2006;86:805-47. [PMID: 16816139 DOI: 10.1152/physrev.00014.2005] [Cited by in Crossref: 302] [Cited by in F6Publishing: 281] [Article Influence: 20.1] [Reference Citation Analysis]